Low-dose hydrocortisone therapy attenuates septic shock in adult patients but does not reduce 28-day mortality: A meta-analysis of randomized controlled trials

Anesthesia and Analgesia

Volumn 118, Issue 2, 2014, Pages 346-357

  Wang, Changsong ^a   Sun, Jiaxiao ^a,b   Zheng, Juanjuan ^a,b   Guo, Lei ^a   Ma, Hongyan ^a   Zhang, Yang ^a   Zhang, Fengmin ^a   Li, Enyou ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b First Hospital of Quanzhou   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDROCORTISONE; HYDROCORTISONE; PLACEBO;

ARTICLE; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; DRUG EFFICACY; EMBASE; GASTROINTESTINAL HEMORRHAGE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; LOADING DRUG DOSE; LOW DRUG DOSE; MEDLINE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; SENSITIVITY ANALYSIS; SEPTIC SHOCK; STATISTICAL ANALYSIS; SUPERINFECTION; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ADULT; HEMODYNAMICS; HUMANS; HYDROCORTISONE; INFUSIONS, INTRAVENOUS; MODELS, STATISTICAL; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; SHOCK, SEPTIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893256392     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000050     Document Type: Article

References (67)

1. Matot I, Sprung CL. Definition of sepsis. Intensive Care Med 2001;27 Suppl 1:S3-9
2. Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettilä V, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA; OPTIMIST Trial Study Group. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: A randomized controlled trial. JAMA 2003;290:238-47
3. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med 2003;31:946-55
4. Cooperative Study Group. The effectiveness of hydrocortisone in the management of patients with severe infections. JAMA 1963;183:462-5
5. Russell JA. Management of sepsis. N Engl J Med 2006;355:1 699-713
6. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653-8
7. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, Fisher CJ Jr. Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature. Crit Care Med 1995;23:1430-9
8. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for severe sepsis and septic shock: A systematic review and meta-analysis. BMJ 2004;329:480
9. Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, De Gaudio R, Keh D, Kupfer Y, Oppert M, Meduri GU. Corticosteroids in the treatment of severe sepsis and septic shock in adults: A systematic review. JAMA 2009;301: 2362-75
10. Moran JL, Graham PL, Rockliff S, Bersten AD. Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: A Bayesian meta-analytic perspective. Crit Care 2010;14:R134
11. Kalil AC, Sun J. Low-dose steroids for septic shock and severe sepsis: The use of Bayesian statistics to resolve clinical trial controversies. Intensive Care Med 2011;37:420-9
12. Czock D, Keller F, Rasche FM, Häussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 2005;44:61-98
13. Lau J, Schmid CH, Chalmers TC. Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol 1995;48:45-57
14. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55
15. Kaufmann I, Briegel J, Schliephake F, Hoelzl A, Chouker A, Hummel T, Schelling G, Thiel M. Stress doses of hydrocortisone in septic shock: Beneficial effects on opsonization-dependent neutrophil functions. Intensive Care Med 2008;34:344-9
16. Bañares R, Albillos A, Rincón D, Alonso S, González M, Ruiz-del-Arbol L, Salcedo M, Molinero LM. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta-analysis. Hepatology 2002;35:609-15
17. Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: Meta-analysis. BMJ 2008;336:1006-9
18. Spruance SL, Reid JE, Grace M, Samore M. Hazard ratio in clinical trials. Antimicrob Agents Chemother 2004;48:2787-92
19. Moran J, Solomon P, Warn D. Methodology in meta-analysis: A study from Critical Care meta-analytic practice. Health Serv Outcomes Res Method 2004;5:207-26
20. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60
21. Chawla K, Kupfer Y, Tessler S. Hydrocortisone reverses refractory septic shock (abstract). Crit Care Med 1999;27:A33
22. Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaud P, Chaumet-Riffaut P, Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71
23. Mussack T, Briegel J, Schelling G, Biberthaler P, Jochum M. Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock. Clin Chem Lab Med 2005;43:259-68
24. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J; CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-24
25. Arabi YM, Aljumah A, Dabbagh O, Tamim HM, Rishu AH, Al-Abdulkareem A, Knawy BA, Hajeer AH, Tamimi W, Cherfan A. Low-dose hydrocortisone in patients with cirrhosis and septic shock: A randomized controlled trial. CMAJ 2010;182:1971-7
26. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999;27:723-32
27. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998;26:645-50
28. Oppert M, Schindler R, Husung C, Offermann K, Gräf KJ, Boenisch O, Barckow D, Frei U, Eckardt KU. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005;33:2457-64
29. Sligl WI, Milner DA Jr, Sundar S, Mphatswe W, Majumdar SR. Safety and efficacy of corticosteroids for the treatment of septic shock: A systematic review and meta-analysis. Clin Infect Dis 2009;49:93-101
30. Annane D, Cariou A, Maxime V, Azoulay E, D'honneur G, Timsit JF, Cohen Y, Wolf M, Fartoukh M, Adrie C, Santré C, Bollaert PE, Mathonet A, Amathieu R, Tabah A, Clec'h C, Mayaux J, Lejeune J, Chevret S. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: A randomized controlled trial. JAMA 2010;303:341-8
31. Cicarelli DD, Vieira JE, Benseñor FE. Early dexamethasone treatment for septic shock patients: A prospective randomized clinical trial. Sao Paulo Med J 2007;125:237-41
32. Yildiz O, Doganay M, Aygen B, Güven M, Keletimur F, TutuÛ A. Physiological-dose steroid therapy in sepsis [ISRCTN36253388]. Crit Care 2002;6:251-9
33. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R. Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial. Chest 2007;131:954-63
34. Yu TJ, Liu YC, Yu CC, Tseng JC, Hua CC, Wu HP. Comparing hydrocortisone and methylprednisolone in patients with septic shock. Adv Ther 2009;26:728-35
35. Levy H, Laterre PF, Bates B, Qualy RL. Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated). Crit Care 2005;9:R502-7
36. Raurich JM, Llompart-Pou JA, Ibáñez J, Frontera G, Pérez O, García L, Ayestarán JI. Low-dose steroid therapy does not affect hemodynamic response in septic shock patients. J Crit Care 2007;22:324-9
37. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637
38. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 1976;184:333-41
39. Lucas CE, Ledgerwood AM. The cardiopulmonary response to massive doses of steroids in patients with septic shock. Arch Surg 1984;119:537-41
40. Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, Duncan RC, Tendler MD, Karpf M. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 1984;311:1137-43
41. Hughes GS Jr. Naloxone and methylprednisolone sodium succinate enhance sympathomedullary discharge in patients with septic shock. Life Sci 1984;35:2319-26
42. Lederer V. Betamethasone sodium phosphate injection: High-dose regimen in septic shock. Clin Ther 1984;6:719-26
43. Hellman A, Alestig K. High doses of corticosteroids in the treatment of septic shock. Acta Chir Scand Suppl 1985;526:124-8
44. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653-8
45. Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988;138:62-8
46. Marks JD, Marks CB, Luce JM, Montgomery AB, Turner J, Metz CA, Murray JF. Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis 1990;141:94-7
47. Oppert M, Reinicke A, Gräf KJ, Barckow D, Frei U, Eckardt KU. Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock. Intensive Care Med 2000;26:1747-55
48. Briegel J, Jochum M, Gippner-Steppert C, Thiel M. Immunomodulation in septic shock: Hydrocortisone differentially regulates cytokine responses. J Am Soc Nephrol 2001;12 Suppl 17:S70-4
49. Annane D, Bellissant E. Impact of corticosteroids on the vascular response to catecholamines in septic shock. Réanimation 2002;11:111-6
50. Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ, Gerlach H. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: A double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003;167:512-20
51. Laterre PF, Levy H, Bates BM. Steroid use in prowess patients with septic shock (abstract). Intensive Care Medicine 2003;29:S89
52. Guzman JA; Bander JJ. Guzman CB. Steroids in septic shock; Limited value of cortisol testing to guide replacement therapy. Critical Care Medicine 2005;33:A169
53. Tandan SM, Guleria R, Gupta N. Low dose steroids and adrenocortical insufficiency in septic shock: A double-blind randomised controlled trial from India. In: Proceedings of the American Thoracic Society Meeting. New York, NY: American Thoracic Society 2005:A24
54. Rinaldi S, Adembri C, Grechi S, De Gaudio AR. Low-dose hydrocortisone during severe sepsis: Effects on microalbuminuria. Crit Care Med 2006;34:2334-9
55. Loisa P, Parviainen I, Tenhunen J, Hovilehto S, Ruokonen E. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: A prospective randomized trial. Crit Care 2007;11:R21
56. McGee WT, Higgins TL, Jodka P. Optimal steroid therapy may improve outcome in septic shock (abstract). Crit Care Med 2007;12:A117
57. Cicarelli DD, Vieira JE, Benseñor FE. Comparison of C-reactive protein and serum amyloid a protein in septic shock patients. Mediators Inflamm 2008;2008:631414.
58. Kurugundla N, Irugulapati L, Kilari D. Effect of steroids in septic shock patients without relative adrenal insufficiency-A pilot study [abstract]. American Thoracic Society: International Conference 2008:A116
59. Büchele GL, Silva E, Ospina-Tascón GA, Vincent JL, De Backer D. Effects of hydrocortisone on microcirculatory alterations in patients with septic shock. Crit Care Med 2009;37:1341-7
60. Hayashi M. Activated protein c and corticosteroids decrease the rate of albumin transudation in septic shock (abstract). Crit Care Med 2009;34:A407
61. Hu B, Li JG, Liang H, Zhou Q, Yu Z, Li L, Luo Y, Liu C, Gan Q. [The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2009;21:529-31
62. Russell JA, Walley KR, Gordon AC, Cooper DJ, Hébert PC, Singer J, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ; Dieter Ayers for the Vasopressin and Septic Shock Trial Investigators. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med 2009;37:811-8
63. Valoor HT, Singhi S, Jayashree M. Low-dose hydrocortisone in pediatric septic shock: An exploratory study in a third world setting. Pediatr Crit Care Med 2009;10:121-5
64. Beale R, Janes JM, Brunkhorst FM, Dobb G, Levy MM, Martin GS, Ramsay G, Silva E, Sprung CL, Vallet B, Vincent JL, Costigan TM, Leishman AG, Williams MD, Reinhart K. Global utilization of low-dose corticosteroids in severe sepsis and septic shock: A report from the PROGRESS registry. Crit Care 2010;14:R102
65. Jung B, Nougaret S, Chanques G, Mercier G, Cisse M, Aufort S, Gallix B, Annane D, Jaber S. The absence of adrenal gland enlargement during septic shock predicts mortality: A computed tomography study of 239 patients. Anesthesiology 2011;115:334-43
66. Schelling G, Briegel J, Roozendaal B, Stoll C, Rothenhäusler HB, Kapfhammer HP. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors. Biol Psychiatry 2001;50:978-85
67. Huh JW, Choi HS, Lim CM, Koh Y, Oh YM, Shim TS, Lee SD, Kim WS, Kim DS, Hong SB. Low-dose hydrocortisone treatment for patients with septic shock: A pilot study comparing 3 days with 7 days. Respirology 2011;16:1088-95